Patients who use GLP1 drugs to help control their type 2 diabetes are at an upward risk of developing age-related macular ...

Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition ...

Body image is part physical and part mental. If weight loss alone isn't helping, strategies from body image psychology can ...

These five Dow Jones industrial companies have paid dividends to shareholders for at least 100 years, perfect ideas for ...

Weight-loss drugs are already dropping in price; could they go even lower? - Consumers are now able to pay roughly $500 for ...

GLP-1s are gaining interest for their impact on weight, blood sugar, and possibly mood in bipolar disorder. Here’s what ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

Omada Health shares climbed after the company made its debut on Nasdaq. The virtual healthcare company started trading shares at $19 on Friday morning, and they jumped 35% to $25.58 by midday. It ...